IRIS
CONIGLIARO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.291
AS - Asia 4.072
EU - Europa 2.791
SA - Sud America 517
AF - Africa 90
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 4
Totale 28.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.165
SG - Singapore 1.882
CN - Cina 882
RU - Federazione Russa 498
IT - Italia 458
HK - Hong Kong 446
BR - Brasile 437
VN - Vietnam 319
DE - Germania 309
IE - Irlanda 292
FR - Francia 278
UA - Ucraina 201
FI - Finlandia 189
GB - Regno Unito 186
JP - Giappone 118
SE - Svezia 71
CA - Canada 70
KR - Corea 70
NL - Olanda 66
IN - India 64
ID - Indonesia 55
PL - Polonia 51
AU - Australia 46
NZ - Nuova Zelanda 43
DK - Danimarca 37
MX - Messico 36
TW - Taiwan 36
AR - Argentina 31
BE - Belgio 31
ZA - Sudafrica 31
ES - Italia 30
AT - Austria 27
TR - Turchia 27
BD - Bangladesh 22
EG - Egitto 22
SA - Arabia Saudita 21
IR - Iran 19
UZ - Uzbekistan 17
EC - Ecuador 14
MA - Marocco 13
PK - Pakistan 13
IQ - Iraq 12
LV - Lettonia 11
CO - Colombia 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
RO - Romania 9
AZ - Azerbaigian 8
PH - Filippine 8
CH - Svizzera 7
CL - Cile 6
KZ - Kazakistan 6
MY - Malesia 6
TN - Tunisia 6
ET - Etiopia 5
HU - Ungheria 5
SI - Slovenia 5
VE - Venezuela 5
BG - Bulgaria 4
JM - Giamaica 4
OM - Oman 4
PE - Perù 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
KE - Kenya 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
SV - El Salvador 3
TH - Thailandia 3
UY - Uruguay 3
YE - Yemen 3
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
KH - Cambogia 1
LK - Sri Lanka 1
Totale 28.844
Salva come PNG Salva come JPEG
Città #
Wilmington 5.506
Houston 4.796
Woodbridge 4.462
Singapore 997
Fairfield 634
Ann Arbor 528
Ashburn 509
Hong Kong 433
Chandler 426
Dallas 401
San Jose 372
Beijing 274
Seattle 264
Dublin 238
Cambridge 212
New York 190
Medford 177
Jacksonville 158
Santa Clara 146
The Dalles 146
Rome 141
Helsinki 132
Council Bluffs 128
Los Angeles 125
Ho Chi Minh City 114
Tokyo 89
Dearborn 87
Moscow 83
Lawrence 82
Lauterbourg 77
São Paulo 62
Buffalo 59
Zhengzhou 59
Hanoi 57
Redwood City 49
London 48
Tauranga 42
Munich 39
Orem 38
San Diego 36
Copenhagen 33
Jakarta 33
Toronto 33
Seoul 32
Boardman 31
Shenzhen 31
Amsterdam 30
Chengdu 30
Nuremberg 29
Nanjing 28
Kraków 27
Menlo Park 27
Brussels 26
Guangzhou 26
Chicago 25
Milan 25
Stockholm 25
Frankfurt am Main 24
Johannesburg 24
Redondo Beach 23
Taipei 22
Warsaw 22
North Bergen 21
Shanghai 21
Denver 20
Melbourne 20
Phoenix 20
Montreal 19
Chaozhou 18
Dong Ket 18
Suzhou 18
Brooklyn 17
Chennai 17
Mülheim 16
Haiphong 15
Jeddah 15
Boston 14
Palo Alto 14
Augusta 13
Norwalk 13
Bassano del Grappa 12
Hefei 12
Lappeenranta 12
Leawood 12
Mumbai 12
Rio de Janeiro 12
San Francisco 12
Tanta 12
Brasília 11
Center 11
Kunming 11
Mexico City 11
Mountain View 11
Atlanta 10
Chongqing 10
Las Vegas 10
Manchester 10
Sydney 10
Ankara 9
Cincinnati 9
Totale 23.550
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 834
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 539
Complement, infection, and autoimmunity 523
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 511
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 510
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 505
Autoantibodies in inflammatory arthritis 500
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 493
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 471
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 467
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 463
Characterization of the anticollagen antibody response in a new model of chronic polyarthritis. 460
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 454
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 453
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 451
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 450
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. 448
The type I IFN system in rheumatoid arthritis 445
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 445
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 444
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 442
Identifying the cells breaching self-tolerance in autoimmunity. 434
Seronegative autoimmune diseases 430
Lymph node IL-18 expression in adult-onset Still's disease. 425
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 424
Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. 424
Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres 424
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 423
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 419
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 409
Insights on the role of physical activity in patients with rheumatoid arthritis 408
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 406
The interplay between inflammation and metabolism in rheumatoid arthritis 405
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate 399
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 389
Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation 383
Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. 373
Natural killer and b cells in patients with rheumatoid arthritis and psoriatic arthritis treated with etanercept 362
Histopathology of the skin in rheumatic diseases 362
The complex interplay between rheumatoid arthritis and atopy: Focus on anti-TNFα treatment 358
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 356
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. 355
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 341
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 337
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 315
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. 309
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients 307
null 287
Interaction between microbiome and host genetics in psoriatic arthritis 283
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 271
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 246
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 244
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 243
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 243
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 231
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 224
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 221
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 220
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 220
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 218
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 190
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 190
Severe lupus nephritis: an unexpected association with Fabry disease 185
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 175
Correspondence to ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga and Liew—gender discrepancies at annual EULAR congresses: towards the gap narrowing 169
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 166
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 161
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 160
COVID-19: disCOVering the role of complement system 159
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 156
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 153
Gender equality in Rheumatology 150
Validation of “Clinical Red Flags” for RA-ILD in an Italian cohort 148
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 148
Tackling the autoimmune side in Spondyloarthritis: a systematic review 142
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 131
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study 125
The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart 123
Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE 120
The steroid-sparing effect of JAK inhibitors across multiple patient populations 113
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 111
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 105
Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome 104
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 99
Alteration of telomere length and mtDNA copy number in interstitial lung disease associated with rheumatoid arthritis 97
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 97
The effects of smoking, alcohol, and dietary habits on the progression and management of spondyloarthritis 96
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 95
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 91
The rs11568820 Variant in the Promoter Region of Vitamin D Receptor Gene Is Associated with Clinical Remission in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors 84
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 83
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 82
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 76
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 75
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 75
Kinesiophobia as part of the psychological burden in Spondyloarthritis: a case-control study 73
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 72
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population 71
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 70
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 70
Totale 28.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.101
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021298 0 0 0 0 0 0 0 0 0 115 139 44
2021/2022856 37 82 75 58 29 50 40 48 46 66 94 231
2022/20231.178 108 99 40 139 103 259 108 89 116 23 66 28
2023/2024580 60 17 22 15 68 133 15 77 26 19 42 86
2024/20252.862 87 548 361 156 34 260 122 118 228 252 368 328
2025/20265.568 380 398 845 659 544 238 766 620 588 530 0 0
Totale 29.343